Stoke Therapeutics Inc

STOK NASDAQ Santé & Biotech États-Unis US86150R1077
30.00 $
0.60 %

Stoke Therapeutics est axée sur le développement de thérapies génétiques pour le traitement de maladies génétiques graves affectant principalement les enfants.

Performance & Momentum

6 Months 9.58 %
1 Year 158.63 %
3 Years 139.33 %
5 Years 23.01 %

Similar stocks to Stoke Therapeutics Inc

Anantys Community

Be the first to share your analysis on Stoke Therapeutics Inc.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases